Daily Target 2X Long HIMS ETF (HIMZ) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerDaily Target 2X Long HIMS ETF (HIMZ) trades at $26.74. Sector: Financials.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for HIMZ: HIMZ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
Daily Target 2X Long HIMS ETF (HIMZ) Financial Services Profile
Daily Target 2X Long HIMS ETF (HIMZ) is a leveraged exchange-traded fund aiming for twice the daily performance of Hims & Hers Health, Inc. (HIMS). It provides a high-risk, high-reward option for investors seeking amplified short-term exposure to HIMS, operating within the volatile asset management sector.
What Is the Investment Thesis for HIMZ?
HIMZ offers a high-risk, high-reward proposition for investors with a short-term bullish outlook on Hims & Hers Health, Inc. (HIMS). The ETF's primary value driver is its 2x leveraged exposure to HIMS's daily price movements. A positive catalyst for HIMZ would be strong positive earnings announcements or favorable market sentiment towards HIMS, potentially leading to amplified gains. However, the ETF's leveraged structure also magnifies losses, making it highly sensitive to any negative news or downturns affecting HIMS. The fund's daily reset feature prevents it from accurately tracking 200% of HIMS's cumulative return over longer periods, introducing tracking error and potential decay, especially in volatile markets. Investors should carefully consider their risk tolerance and time horizon before investing in HIMZ.
Based on FMP financials and quantitative analysis
HIMZ Key Highlights
HIMZ seeks daily investment results of two times (200%) the daily percentage change in the share price of Hims & Hers Health, Inc. (NYSE: HIMS).
- The fund is designed for short-term tactical plays and is not intended as a long-term investment vehicle.
- HIMZ's leveraged nature means it is designed for sophisticated investors who actively monitor their positions and understand the risks associated with leveraged ETFs.
- The fund's performance is highly sensitive to news, market sentiment, and company-specific events affecting Hims & Hers Health, Inc.
- HIMZ has a market capitalization of $0.01 billion, indicating its relatively small size within the ETF market.
Who Are HIMZ's Competitors?
HIMZ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| DIG ProShares - Ultra Energy | $69.29 | +0.90% | $72.0M | — |
| FDIV MarketDesk Focused U.S. Dividend ETF | $26.40 | +0.64% | $68.6M | — |
| FGM First Trust Germany AlphaDEX Fund | $58.39 | +0.38% | $90.6M | — |
| IAUG Innovator Intl Developed Power Buffer ETF | $30.28 | +0.09% | $70.9M | — |
| RCGE RockCreek Global Equality ETF | $29.07 | -3.59% | $90.1M | — |
| BLK BlackRock, Inc. | $1079.42 | +1.22% | $167B | 51 5-pillar |
| BX Blackstone Inc. | $113.36 | +1.54% | $137B | 66 5-pillar |
| APOS Apollo Global Management, Inc. | $25.60 | +0.04% | $74.9B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HIMZ's Key Strengths?
Offers 2x leveraged exposure to Hims & Hers Health, Inc. (HIMS).
- Designed for short-term tactical trading.
- Provides a way to potentially amplify gains in HIMS.
- Trades on the stock market like any other ETF.
What Are HIMZ's Weaknesses?
Leveraged nature magnifies losses.
- Daily reset can lead to tracking error over longer periods.
- High-risk investment suitable only for sophisticated investors.
- Performance is highly dependent on HIMS's stock price.
What Are the Key Risks for HIMZ?
Negative news or events affecting Hims & Hers Health, Inc. (HIMS) could lead to significant losses.
- The leveraged nature of HIMZ magnifies both gains and losses.
- The daily reset feature can lead to tracking error and potential decay over longer periods.
- Changes in regulations governing leveraged ETFs could impact the fund's operations.
What Are HIMZ's Competitive Advantages?
- Leveraged Exposure: Offers a unique 2x leveraged exposure to Hims & Hers Health, Inc. (HIMS), attracting investors seeking amplified returns.
- Daily Reset: The daily reset feature allows for tactical short-term trading strategies.
- Niche Focus: Concentrates specifically on HIMS, catering to investors with strong views on the company's prospects.
What Does HIMZ Do?
The Defiance Daily Target 2X Long HIMS ETF (HIMZ) is designed for investors seeking to magnify the daily investment results of Hims & Hers Health, Inc. (NYSE: HIMS). Launched by Defiance ETFs, HIMZ aims to provide twice (200%) the daily percentage change in the share price of HIMS. It is crucial to understand that HIMZ is not intended as a long-term investment vehicle. Its leveraged nature means it is designed for short-term tactical plays, and its performance can deviate significantly from 200% of the cumulative return of HIMS over periods longer than a single trading day. The fund employs financial strategies to achieve its daily objectives, making it a specialized tool within the broader asset management landscape. HIMZ caters to sophisticated investors who actively monitor their positions and understand the risks associated with leveraged ETFs. The fund's success hinges on the daily movements of HIMS, making it highly sensitive to news, market sentiment, and company-specific events affecting Hims & Hers Health, Inc.
What Products and Services Does HIMZ Offer?
- Seeks daily investment results of two times (200%) the daily percentage change in the share price of Hims & Hers Health, Inc. (NYSE: HIMS).
- Offers a leveraged investment strategy for short-term trading.
- Provides investors with a way to potentially amplify gains or losses based on HIMS's stock performance.
- Utilizes financial instruments to achieve its daily leverage target.
- Resets its leverage daily, which can lead to tracking error over longer periods.
- Trades on the stock market like any other exchange-traded fund (ETF).
How Does HIMZ Make Money?
- HIMZ generates revenue through management fees charged to investors.
- The fund's performance is directly tied to the daily price movements of Hims & Hers Health, Inc. (HIMS).
- It aims to provide twice (200%) the daily percentage change in HIMS's share price.
What Industry Does HIMZ Operate In?
HIMZ operates within the asset management industry, specifically in the niche of leveraged ETFs. This segment is characterized by high volatility and is geared towards sophisticated investors seeking to amplify short-term gains or losses. The broader asset management industry is experiencing growth driven by increasing investor interest in ETFs and other investment vehicles. However, leveraged ETFs like HIMZ carry inherent risks due to their amplified exposure and daily reset mechanisms. Competitors in this space include other leveraged ETFs and inverse ETFs, such as DIG, FDIV, FGM, IAUG, and RCGE, which offer similar strategies but focus on different underlying assets or market segments.
Who Are HIMZ's Key Customers?
- Sophisticated investors seeking leveraged exposure to Hims & Hers Health, Inc. (HIMS).
- Short-term traders looking to capitalize on daily price movements in HIMS.
- Investors with a high-risk tolerance who understand the risks associated with leveraged ETFs.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is an etf, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 43 snapshots
| 2026-08-23 | 44 |
| 2026-08-31 | 44 |
| 2026-09-08 | 44 |
| 2026-09-16 | 44 |
| 2026-09-24 | 44 |
| 2026-10-04 | 44 |
| 2026-10-06 | 44 |
What changed?
The score has stayed at 44.
Over the same 30 days the stock moved +10.9%.
HIMZ Financials
Bull Case vs Bear Case
Bull Case
- Offers 2x leveraged exposure to Hims & Hers Health, Inc. (HIMS).
- Designed for short-term tactical trading.
- Provides a way to potentially amplify gains in HIMS.
- Trades on the stock market like any other ETF.
Bear Case
- Leveraged nature magnifies losses.
- Daily reset can lead to tracking error over longer periods.
- High-risk investment suitable only for sophisticated investors.
- Performance is highly dependent on HIMS's stock price.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
HIMZ Latest News
No recent news available for HIMZ.
HIMZ Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for HIMZ.
Price Targets
Wall Street price target analysis for HIMZ.
HIMZ MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for HIMZ; grades run from A+ (80-100) to F (below 30).
Common Questions About HIMZ (Financials)
What does Daily Target 2X Long HIMS ETF do?
The Daily Target 2X Long HIMS ETF (HIMZ) is a leveraged exchange-traded fund designed to deliver twice the daily percentage change in the share price of Hims & Hers Health, Inc. (HIMS).
What do analysts say about HIMZ stock?
As a leveraged ETF, HIMZ is not typically covered by analysts in the same way as individual stocks. However, analysts who cover Hims & Hers Health, Inc. (HIMS) may provide insights into factors that could influence HIMZ's performance. Key valuation metrics for HIMZ are less relevant than understanding the drivers of HIMS's stock price.
What are the main risks for HIMZ?
The main risks for HIMZ stem from its leveraged nature and its dependence on the daily price movements of Hims & Hers Health, Inc. (HIMS). The leveraged structure magnifies both gains and losses, making HIMZ highly sensitive to any negative news or downturns affecting HIMS.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The information provided is based on available data and is for informational purposes only. It is not investment advice. Investors should conduct their own research and consult with a financial advisor before making any investment decisions.
- Leveraged ETFs are complex financial instruments and are not suitable for all investors.
- Past performance is not indicative of future results.